An observational study in Stroke, Rehabilitation and Co-design, sponsored by University of Plymouth. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-20.
Sponsored by University of Plymouth · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 372 studies in Stroke with a site in United Kingdom — 60 open to participants now, 80 under way, 8 of them phase 3. Stroke · United Kingdom.
Among the 372 studies in Stroke with a site in United Kingdom, this one is the 91st largest by planned enrollment of the 115 observational ones that give a count, is one of 6 that started in 2026, is one of 115 observational ones, reaches primary completion later than 47 of the 79 other live ones, and was the 363rd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →60 of the 372 studies in Stroke with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Oxford · Sites in United Kingdom
Ages 18+ · Healthy volunteers
Imperial College London · Sites in United Kingdom
Ages 18+
Oxford University Hospitals NHS Trust · Sites in United Kingdom
Ages 18+
Glasgow Caledonian University · Sites in United Kingdom
Ages 16+
Eli Lilly and Company · Sites in United Kingdom, Argentina, Australia and 35 more countries
Ages 50+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
372 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 35 · Phase 3 51 · Phase 4 14
First in 1997; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 38 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 62 across the 257 interventional studies, 198 across the 115 observational. Of the 238 that completed or were terminated, 51 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
79 of 372 have an industry lead sponsor. The 10 most frequent:
University of Plymouth is the lead sponsor of 49 studies on the registry; 16 are open to participants now.
University of Plymouth has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
15 of the studies in Stroke with a site in United Kingdom that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05065216Phase 3DiaMedica Therapeutics IncTreatment of Acute Ischemic Stroke (ReMEDy2 Trial) | 2026-12 |
| NCT05691244Phase 3Pharmazz, Inc.Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | 2027-09 |
| NCT05298436Guy's and St Thomas' NHS Foundation TrustThe South London Stroke Register: Improving the Lives of Stroke Survivors With Data | 2026-12 |
| NCT06263920Lancashire Teaching Hospitals NHS Foundation TrustNeurofrailty: A Study of Late-onset Epilepsy and Its Associations | 2027-01-12 |
| NCT07484958University of PlymouthCo-designing a Stroke Rehabilitation Trial Toolkit | 2027-01-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 372 studies in Stroke with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Clinical trials are a type of research that tests if a treatment works well and is safe, so future care can be improved. In stroke rehabilitation, clinical trials are essential for improving the lives of stroke survivors. Clinical trials follow detailed plans called protocols, that explain what activities should be done, by whom and when. This makes sure everyone in the trial does things the same way, so results are fair and consistent. Sometimes, stroke survivors or staff may not follow the trial protocol exactly. For example, someone might miss a session or do different exercises. This is called low adherence. There are many reasons this can happen; the exercises or schedule may be too hard, the trial or activities do not match what stroke survivors or staff need, prefer, or find helpful in real life. If protocols are not followed properly, the trial results of clinical trials may not be reliable. This can slow down the process of getting better treatments into hospitals and make it harder to improve rehabilitation for future stroke survivors.
Previous research has looked at what helps and gets in the way of adhering to protocols during hospital-based stroke rehabilitation trials. The research has identified many factors, including the healthcare system, hospital environment, staff, patients and the rehabilitation activities or schedules. Most of this research focused on the views of staff involved, meaning important perspectives may be missing from others involved in stroke rehabilitation trials.
The investigators' study aims to change that. The investigators want to hear from people whose voices are often overlooked: stroke survivors, their family and friends, stroke rehabilitation staff and healthcare leaders working in the NHS, stroke rehabilitation researchers, staff working in Integrated Care Boards (who help plan and coordinate NHS services in local areas) and representatives from organisations who fund stroke rehabilitation research. The investigators will use a process called co-design. This means working together to develop a toolkit to help improve adherence in future stroke rehabilitation trials.
Toolkits are already used in healthcare to help people do things better. For example, changing how care is given, supporting patients, or helping health teams work more smoothly. But currently, there is no toolkit designed specifically to help improve adherence to stroke rehabilitation trial protocols.
This research aims to design a toolkit together. The toolkit will be shaped by a wide range of voices, especially those from underrepresented groups, and made in a way that's easy to understand and use.
By addressing potential barriers early on, the investigators hope the toolkit will make it easier for future stroke rehabilitation trials to succeed, leading to better recovery and quality of live for stroke survivors.
Robust stroke rehabilitation trials are essential for advancing evidence-based practice. These trials rely on adherence to detailed protocols that specify the treatment content, delivery, frequency, and data collection methods. However, when protocols are not adhered to (low adherence) this compromises the reliability and validity of trial outcomes, leading to research waste and delays translating evidence into clinical practice, ultimately hindering recovery for stroke survivors.
A mixed-methods systematic review of hospital-based rehabilitation clinical trials identified multiple barriers and facilitators to protocol adherence for hospital-based rehabilitation trials: innovation (rehabilitation intervention), outer setting (healthcare system), inner setting (hospital/organisation), individuals (leaders, intervention deliverers and recipients) and implementation (activities/strategies to deliver the intervention). The systematic review provides critical insights to inform future trial design and implementation. However, the findings predominantly reflect staff perspectives and are drawn from individual stroke rehabilitation trials, potentially limiting generalisability across broader contexts. Thus, the aim of the research is to gather underrepresented voices to understand the knowledge, skills, techniques and behaviours needed to improve and maintain adherence to stroke rehabilitation protocols. The investigators will work together with stroke survivors, family member/friend of stroke survivor, stroke rehabilitation staff and researchers, healthcare leaders, staff from Integrated Care Board/Systems and funders (hereon in referred to as research partners) using Experience-Based Co-Design (EBCD). EBCD brings together lived experience, lived expertise and professional experience to learn from each other to design a toolkit that meets the needs and preferences of all.
Toolkits have been widely used in health as a way of knowledge translation, aim to improve behaviours among healthcare staff, consumers, organisations, policy makers and the public. They typically consist of a collection of resources practical tools designed to support the implementation and uptake of a treatment or process. The content and format of toolkits can vary depending on the health condition, target users, clinical setting, and individual needs and preferences. However, there is no existing toolkit to help improve adherence in stroke rehabilitation clinical trials. This study specifically addresses the need to develop a toolkit to optimise adherence to inpatient stroke rehabilitation clinical trial protocols.
The investigators will co-design a toolkit based on the diverse needs and priorities of the research partners and will incorporate evidence-based methods to ensure reach to underserved groups. They will ensure that the languages, strategies and information is accessible and relatable to different communities of individuals.
The investigators will consider potential barriers and solutions to implementation throughout to ensure successful adoption of a toolkit in future inpatient stroke rehabilitation trials.
Stroke survivors, family member or friend of stroke survivor, stroke rehabilitation staff, healthcare leaders, stroke rehabilitation researchers, funders of stroke rehabilitation research.
Participants will be eligible if they meet the following criteria:
8.1.1 Inclusion criteria stroke survivors
8.1.2 Inclusion criteria family member/friend of stroke survivor
8.1.3 Inclusion criteria stroke rehabilitation staff
8.1.4 Inclusion criteria healthcare leaders (e.g., Managers, Administrators, Policy Makers)
8.1.5 Inclusion criteria stroke rehabilitation researchers
8.1.6 Inclusion criteria for funders
8.2 Exclusion Criteria
Participants will not be eligible if they meet any the following criteria:
8.2.1 Exclusion criteria for stroke survivors
8.2.2 Exclusion criteria for family member/friend of stroke survivor
8.2.3 Exclusion criteria for stroke rehabilitation staff
8.2.4 Exclusion criteria for healthcare leaders (e.g., Managers, Administrators, Policy Makers)
8.2.5 Exclusion criteria for stroke rehabilitation researchers
8.2.6 Exclusion criteria for funders
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Stroke survivors aged 18 years and over
Other: Co-designing a stroke rehabilitation toolkit
Staff with more than 6 months experience of working in inpatient stroke rehabilitation, e.g., nurse, occupational therapist, physiotherapist, rehabilitation physician
Other: Co-designing a stroke rehabilitation toolkit
Individuals who are accountable and responsible for the operational, clinical, and/or strategic delivery of stroke rehabilitation, rehabilitation and/or therapy services within a NHS hospital * Individuals working in an Integrated Care Board with rehabilitation and/or research in their portfolio * Experience in implementing/influencing stroke rehabilitation policy/service delivery
Other: Co-designing a stroke rehabilitation toolkit
Active researchers with experience in designing, conducting and evaluating stroke rehabilitation or physical rehabilitation research * Affiliated with academic or research institutions * Willing to participate in co-design activities and share their perspectives.
Other: Co-designing a stroke rehabilitation toolkit
* Currently employed, contracted to, or formally affiliated with a research funding organisation that reviews, commissions or funds stroke rehabilitation research (e.g., NIHR, Stroke Association, research councils, medical research councils, professional bodies or research charities) * Direct involvement in decision-making, monitoring or governance of stroke rehabilitation research within the past two years * Experience with funding processes related to stroke rehabilitation, rehabilitation or clinical trial oversight
Other: Co-designing a stroke rehabilitation toolkit
* Adults (aged 18+) who are a family member, friend, or informal caregiver of a stroke survivor. * Able and willing to provide informed consent. * Willing to participate in co-design activities and share their perspectives.
Other: Co-designing a stroke rehabilitation toolkit
STAGE 1 NATIONAL ONLINE SURVEY: to capture a broad range of views from those involved in stroke rehabilitation trials, e.g. all groups. This will help identify key themes for deeper exploration in STAGE 2. STAGE 2 INTERVIEWS: with up to 14 participants, a mix of research partners. Interviews will be online via Zoom or Microsoft Teams. Interviews will be audio recorded. A short film, called a catalyst film, will be created from the survey and interviews. STAGE 3 JOINT DISCUSSIONS: Approximately 16 participants; a mix of all groups will attend a 2-hour joint event. The catalyst film created from STAGES 1 and 2 will be shown. STAGE 4 CO-DESIGN WORKSHOPS: Three co-design workshops will take place over the course of 8 weeks. Up to 20 participants (a mix of groups). STAGE 5: CELEBRATION EVENT: showcase the co-designed outcomes, celebrate participant contributions, and share learning with wider stakeholders.
Survey, individual interviews, and group discussions This is co-design research the output will be the co-designed toolkit.
STAGE 1 SURVEYS: Total number of surveys completed which will be categorised by participant groups, e.g., stroke survivors, family/friend of stroke survivor, stroke rehabilitation staff, healthcare leader, stroke rehabilitation researcher, funder. Data will be analysed as follows: * Descriptive statics (frequencies, percentages, and median responses) * Statistical tests (t-tests, ANOVA, correlation) STAGE 2 INTERVIEWS: Data will be analysed using thematic analysis which will inform stages 3 and 4. STAGE 3 JOINT DISCUSSIONS: Approximately 16 participants; a mix of all groups will attend a 2-hour joint event. STAGE 4 CO-DESIGN WORKSHOPS: Three co-design workshops will take place over the course of 8 weeks. Up to 20 participants (a mix of groups).
Time frame: Time Frame: From March 2026 to February 2027
Plan to share: Undecided
Started Feb 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Plymouth